Albumins unique properties offer unlimited potential in the field of medical science.

Learn more


Learn more about our Recombumin® portfolio of recombinant human albumin products.

Show me


Our albumins enable the effective formulation of otherwise hard-to-stabilize drug, vaccine and cell therapies.

Read more


Albumedix has established a strong portfolio of valued partnerships.

Check it out


cGMP Manufacturing

Batch-to-Batch Consistency

Regulatory Support

High Quality Products

Technical Support

Consistent supply


11th Global Drug Delivery & Formulation Summit, 2020

From March 9 - 11th, 2020 Albumedix will be attending the DDF conference in Berlin. Be sure to come by booth number 6 and have a chat with our representatives!

Read more
Cell Therapy Manufacturing ASIA

On 27th - 28th February 2020, Albumedix will be attending the Cell Therapy Manufacturing ASIA conference in Kyoto, Japan.

Read more
Raising the Standards of Pharmaceutical Excipients – Back from the IPEC Forum

Albumedix attended the International Pharmaceutical Excipients Council (IPEC) Annual Forum and AGM in Aix-en-Provence, France earlier this month.

Read more
What cell and gene therapy trends will we all be talking about in 2020?

Back from Phacilitate conference in Miami, we reflect on the exciting trends and developments presented and cannot wait for what 2020 will bring!

Read more
Albumin: From Peptides, to Proteins, to Viral Vectors

Albumedix has attended PepTalk for many years, and as the world of biopharmaceuticals expands towards more complex entities, albumin will always play a role in the stabilisation of the most challenging APIs. As an example of albumin’s potential in stabilising difficult biopharmaceuticals, we have presented the results obtained for glucagon , a notoriously insoluble and unstable peptide. Albumin was not only able to allow the solubilisation of this APIs in a close-to-physiological conditions, where the peptide is insoluble, but also protected it from chemical and physical degradation in accelerated stability tests.

Read more
Christmas 'Capping Off' Ceremony

In December, Albumedix held a 'Capping off Ceremony' to celebrate the brand new, four-storey manufacturing plant extension being confirmed as watertight!

Read more
Placing Students at the Heart of Albumedix

Our Market Development Team within Albumedix were looking to carry out an extensive market analysis project into one of the many albumin application areas; in order to obtain information and challenge our current perceptions. Incorporating two postgraduate students into this project allowed us to make quick progress and benefit from an expert external perspective simultaneously.

Read more
Albumedix Ground-Breaking Ceremony

May 8th marked a big day in Albumedix’s history. Holding a traditional ground-breaking ceremony; our workforce, builders and contractors all gathered to watch Peter Rosholm (Chief Executive Officer) and Stuart Woodward (Chief Manufacturing Officer) take the first official step towards the company’s expansion.

Read more
Improving patient quality of life by leveraging our unique albumin-based products and technologies.
Dedicated to Better Health